{
  "id": 17870991,
  "title": "Late-Stage Sickle Cell Disease Study Splits on Main Goals",
  "url": "https://urgent.news/2026/11/02/late-stage-sickle-cell-disease-study-splits-on-main-goals",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-02T22:32:15.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/hematologyoncology/hematology/123693"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- The thalassemia drug mitapivat (Aqvesme) significantly improved hemoglobin response in patients with sickle cell disease but failed to top placebo when it came to reducing pain crises in a phase III trial that aims to support...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}